San Jose, CA, United States of America

Wen Yang

This inventor holds 1 USPTO granted patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Yang. Retrieved from https://idiyas.com/inventor/wen-yang-g5f9w6v1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wen Yang in G Protein Coupled Receptor Kinases

Introduction

Wen Yang is an accomplished inventor based in San Jose, CA. She has made significant contributions to the field of biomedical research, particularly in the development of small molecule inhibitors targeting G protein coupled receptor 6 kinases. Her work aims to address critical health issues, including hematological malignancies, inflammatory diseases, and autoimmune disorders.

Latest Patents

Wen Yang holds a patent for "Small molecule inhibitors of G protein coupled receptor 6 kinases polypeptides." This patent relates to the inhibitors of G protein coupled receptor 6 kinase (GRK6) polypeptides, providing methods and materials for utilizing these inhibitors in therapeutic applications.

Career Highlights

Wen Yang is currently associated with the Mayo Foundation for Medical Education and Research, where she continues her research and development efforts. Her innovative work has the potential to lead to new treatment options for various diseases.

Collaborations

Wen collaborates with notable colleagues, including Alexander Keith Stewart and Brian Rich, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Wen Yang's contributions to the field of biomedical research through her innovative patents and collaborations highlight her role as a leading inventor in the development of new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…